Research Frontiers Reports First Quarter 2022 Financial Results and Will Host a Conference Call at 4:30p.m.
May 05 2022 - 04:01PM
GlobeNewswire Inc.
Research Frontiers Inc. (Nasdaq: REFR) announced its financial
results for its March 31, 2022 first quarter. Management will host
a conference call today at 4:30 p.m. Eastern Time to discuss its
financial and operating results as well as recent developments.
- Who: Joseph M. Harary, President &
CEO
- Date/Time: May 5, 2022, 4:30 PM ET
- Dial-in Information: 1-888-334-5785
- Replay: Available on Friday, May 6, 2022 for
90 days at https://smartglass-ir.com/
Key Comments:
-
The Company’s fee income from licensing activities decreased
slightly as a result of two factors (1) lower to flat economic
activity in the various industries that use the Company’s
SPD-SmartGlass technology, and (2) timing differences due to how
revenues are recorded from an accounting standpoint.
- The Company expects revenue in all
market segments to increase beginning later this year as new car
models and other products using the Company’s SPD-SmartGlass
technology are introduced into the market.
- Total expenses decreased by
$21,250, or approximately 3%, for the first quarter ended March 31,
2022 as compared to the same period last year. 2021 was the seventh
consecutive year that expenses were lower than the year before at
Research Frontiers and this trend continued in the first quarter of
2022.
- The Company’s net loss was $628,348
($0.02 per common share) for the quarter ended March 31, 2022 as
compared to $557,307 ($0.02 per common share) for the quarter ended
March 31, 2021.
- As of March 31, 2022, the Company
had cash and cash equivalents of approximately $2.5 million and
working capital of approximately $3.0 million. The Company expects
to have sufficient working capital for at least the next 23 months
of operations.
- This year, new products using the
Company’s SPD-Smart light control technology were featured at the
CES Consumer Electronics Show including automotive and consumer
electronics applications, and a new aircraft model debuted in early
April using electronically dimmable windows.
For more details, please see the Company’s
Annual Report on Form 10-Q which was filed today with the SEC, the
contents of which are incorporated by reference herein.
About Research Frontiers
Research Frontiers (Nasdaq: REFR) is a publicly
traded technology company and the developer of patented SPD-Smart
light-control film technology which allows users to instantly,
precisely and uniformly control the shading of glass or plastic
products, either manually or automatically. Research Frontiers has
licensed its smart glass technology to over 40 companies that
include well known chemical, material science and glass companies.
Products using Research Frontiers’ smart glass technology are being
used in tens of thousands of cars, aircraft, yachts, trains, homes,
offices, museums and other buildings. For more information, please
visit our website at www.SmartGlass.com, and on Facebook, Twitter,
LinkedIn and YouTube.
Note: From time to time Research Frontiers may
issue forward-looking statements which involve risks and
uncertainties. This press release contains forward-looking
statements. Actual results, especially those reliant on activities
by third parties, could differ and are not guaranteed. Any
forward-looking statements should be considered accordingly.
“SPD-Smart” and “SPD-SmartGlass” are trademarks of Research
Frontiers Inc.
CONTACT:Joseph M. HararyPresident and
CEOResearch Frontiers Inc.+1-516-364-1902Info@SmartGlass.com
RESEARCH FRONTIERS INCORPORATEDCondensed
Consolidated Balance Sheets
|
|
March 31, 2022 (Unaudited) |
|
|
December 31, 2021 |
|
Assets |
|
|
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
2,466,373 |
|
|
$ |
269,964 |
|
Marketable securities |
|
|
- |
|
|
|
2,755,111 |
|
Royalty receivables, net of reserves of $1,016,678 in 2022 and
2021 |
|
|
753,550 |
|
|
|
831,636 |
|
Prepaid expenses and other current assets |
|
|
86,573 |
|
|
|
92,931 |
|
|
|
|
|
|
|
|
|
|
Total current assets |
|
|
3,306,496 |
|
|
|
3,949,642 |
|
|
|
|
|
|
|
|
|
|
Fixed assets, net |
|
|
86,379 |
|
|
|
92,954 |
|
Operating lease ROU assets |
|
|
433,473 |
|
|
|
469,824 |
|
Deposits and other assets |
|
|
33,567 |
|
|
|
33,567 |
|
Total assets |
|
$ |
3,859,915 |
|
|
$ |
4,545,987 |
|
|
|
|
|
|
|
|
|
|
Liabilities and Shareholders’ Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
|
|
Current portion of operating lease liability |
|
$ |
186,169 |
|
|
$ |
182,091 |
|
Accounts payable |
|
|
16,023 |
|
|
|
66,460 |
|
Accrued expenses and other |
|
|
74,777 |
|
|
|
49,385 |
|
Deferred revenue |
|
|
10,756 |
|
|
|
- |
|
Total current liabilities |
|
|
287,725 |
|
|
|
297,936 |
|
|
|
|
|
|
|
|
|
|
Operating lease liability, net of current portion |
|
|
416,615 |
|
|
|
464,128 |
|
Total liabilities |
|
|
704,340 |
|
|
|
762,064 |
|
|
|
|
|
|
|
|
|
|
Shareholders’ equity: |
|
|
|
|
|
|
|
|
Common stock, par value $0.0001 per share; authorized 100,000,000
shares, issued and outstanding 31,650,396 in 2022 and 2021 |
|
|
3,165 |
|
|
|
3,165 |
|
Additional paid-in capital |
|
|
123,467,886 |
|
|
|
123,467,886 |
|
Accumulated deficit |
|
|
(120,315,476 |
) |
|
|
(119,687,128 |
) |
Total shareholders’ equity |
|
|
3,155,575 |
|
|
|
3,783,923 |
|
|
|
|
|
|
|
|
|
|
Total liabilities and shareholders’ equity |
|
$ |
3,859,915 |
|
|
$ |
4,545,987 |
|
See accompanying notes to condensed consolidated
financial statements.
RESEARCH FRONTIERS INCORPORATEDCondensed
Consolidated Statements of Operations(Unaudited)
|
|
Three months ended March 31, |
|
|
|
2022 |
|
|
2021 |
|
|
|
|
|
|
|
|
Fee income |
|
$ |
173,828 |
|
|
$ |
213,123 |
|
|
|
|
|
|
|
|
|
|
Operating expenses |
|
|
600,698 |
|
|
|
625,596 |
|
Research and development |
|
|
148,825 |
|
|
|
145,178 |
|
Total expenses |
|
|
749,523 |
|
|
|
770,774 |
|
|
|
|
|
|
|
|
|
|
Operating loss |
|
|
(575,695 |
) |
|
|
(557,651 |
) |
|
|
|
|
|
|
|
|
|
Net investment (loss) income |
|
|
(52,653 |
) |
|
|
344 |
|
|
|
|
|
|
|
|
|
|
Net loss |
|
$ |
(628,348 |
) |
|
$ |
(557,307 |
) |
|
|
|
|
|
|
|
|
|
Basic and diluted net loss per common share |
|
$ |
(0.02 |
) |
|
$ |
(0.02 |
) |
|
|
|
|
|
|
|
|
|
Weighted average number of common shares outstanding |
|
|
31,650,396 |
|
|
|
31,634,890 |
|
See accompanying notes to condensed consolidated
financial statements.
RESEARCH FRONTIERS INCORPORATEDCondensed
Consolidated Statements of Shareholders’ Equity(Unaudited)
For the three months ended March 31, 2021 and 2022
|
|
Common Stock |
|
|
Additional Paid-in |
|
|
Accumulated |
|
|
|
|
|
|
Shares |
|
|
Amount |
|
|
Capital |
|
|
Deficit |
|
|
Total |
|
Balance,
January 1, 2021 |
|
|
31,575,786 |
|
|
$ |
3,158 |
|
|
$ |
123,164,623 |
|
|
$ |
(117,840,776 |
) |
|
$ |
5,327,005 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise
of options |
|
|
74,610 |
|
|
|
7 |
|
|
|
86,255 |
|
|
|
- |
|
|
|
86,262 |
|
Net loss |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(557,307 |
) |
|
|
(557,307 |
) |
Balance,
March 31, 2021 |
|
|
31,650,396 |
|
|
$ |
3,165 |
|
|
$ |
123,250,878 |
|
|
$ |
(118,398,083 |
) |
|
$ |
4,855,960 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance,
January 1, 2022 |
|
|
31,650,396 |
|
|
$ |
3,165 |
|
|
$ |
123,467,886 |
|
|
$ |
(119,687,128 |
) |
|
$ |
3,783,923 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(628,348 |
) |
|
|
(628,348 |
) |
Balance,
March 31, 2022 |
|
|
31,650,396 |
|
|
$ |
3,165 |
|
|
$ |
123,467,886 |
|
|
$ |
(120,315,476 |
) |
|
$ |
3,155,575 |
|
See accompanying notes to condensed consolidated
financial statements.
RESEARCH FRONTIERS INCORPORATEDCondensed
Consolidated Statements of Cash Flows(Unaudited)
|
|
For the three months ended March 31, |
|
|
|
2022 |
|
|
2021 |
|
Cash flows from operating activities: |
|
|
|
|
|
|
|
|
Net loss |
|
$ |
(628,348 |
) |
|
$ |
(557,307 |
) |
Adjustments to reconcile net loss to net cash used in operating
activities: |
|
|
|
|
|
|
|
|
Depreciation and amortization |
|
|
96 |
|
|
|
4,489 |
|
Realized loss on sale of marketable securities |
|
|
60,143 |
|
|
|
- |
|
Change in assets and liabilities: |
|
|
|
|
|
|
|
|
Royalty receivables |
|
|
78,086 |
|
|
|
(139,578 |
) |
Prepaid expenses and other current assets |
|
|
6,358 |
|
|
|
(28,759 |
) |
Accounts payable and accrued expenses |
|
|
(25,045 |
) |
|
|
50,550 |
|
Deferred revenue |
|
|
10,756 |
|
|
|
27,945 |
|
Net cash used in operating activities |
|
|
(497,954 |
) |
|
|
(642,660 |
) |
|
|
|
|
|
|
|
|
|
Cash flows from investing activities: |
|
|
|
|
|
|
|
|
Purchases of fixed assets |
|
|
(605 |
) |
|
|
(346 |
) |
Proceeds from sales of marketable securities |
|
|
2,694,968 |
|
|
|
- |
|
Net cash provided by (used in) investing activities |
|
|
2,694,363 |
|
|
|
(346 |
) |
|
|
|
|
|
|
|
|
|
Cash flows from financing activities: |
|
|
|
|
|
|
|
|
Proceeds from exercise of options |
|
|
- |
|
|
|
86,262 |
|
Net cash provided by financing activities |
|
|
- |
|
|
|
86,262 |
|
|
|
|
|
|
|
|
|
|
Net increase (decrease) in cash and cash equivalents |
|
|
2,196,409 |
|
|
|
(556,744 |
) |
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at beginning of period |
|
|
269,964 |
|
|
|
4,772,705 |
|
Cash and cash equivalents at end of period |
|
$ |
2,466,373 |
|
|
$ |
4,215,961 |
|
See accompanying notes to condensed consolidated
financial statements.
Research Frontiers (NASDAQ:REFR)
Historical Stock Chart
From Jul 2022 to Aug 2022
Research Frontiers (NASDAQ:REFR)
Historical Stock Chart
From Aug 2021 to Aug 2022